• 1
    Ettinger B, Genant HK, Cann CE 1986 Long-term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 156:15161523.
  • 2
    Hutchison TA, Polansky SM, Feinstein AR 1979 Postmenopausal oestrogen protect against fractures of the hip and distal radius. A case-control study. Lancet 2:705709.
  • 3
    Szucs J, Horvatch C, Kollin E, Szathmari M, Hollo I 1992 Three year Calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine. Calcif Tissue Int 50:610.
  • 4
    Wronski TJ, Cinton M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681686.
  • 5
    Burchkhardt P, Burnand B 1993 The effect of treatment with Calcitonin on vertebral fracture rate in osteoporosis. Osteoporos Int 3:2430.
  • 6
    Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A 2000 Alendronate and estrogen effects in postmenopausal woman with low bone mineral density. Alendronate/Estrogen study group. J Clin Endocrinol Metab 85:720726.
  • 7
    Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD 1999 Effects of risedronate treatment on vertebral and nonvertebral fracture in woman with postmenopausal osteoporosis: A randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group. JAMA 282:13441352.
  • 8
    Black DM, Cummings SR, Karpt DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskett WJ, Marcus M, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomized trial of effect of alendronate on risk of fracture in woman with existing vertebral fractures. Lancet 348:15351541.
  • 9
    Lindsay R, Nieves J, Formica C, Hennerman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomized controlled study of effect of parathyroid hormone on vertebral bone mass among postmenopausal woman with osteoporosis. Lancet 350:550555.
  • 10
    Kurland ES, Cosman F, McKahon DJ, Rosen CJ, Lindsay R, Bilezikian JP 2000 Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:30693076.
  • 11
    Bilezikian JP, Kurland ES 2001 Therapy of male osteoporosis with parathyroid hormone. Calcif Tissue Int 69:248251.
  • 12
    Lane NE, Sanchez S, Modin G, Genant HK, Pierini E, Arnaud CD 1998 Parathyroid hormone treatment can reverse steroid osteoporosis: Results of a randomized clinical trial. J Clin Invest 102:16271633.
  • 13
    Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:16181623.
  • 14
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Placetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:18461853.
  • 15
    Lane NE, Thompson JM, Strewler GJ, Kinney JH 1995 Intermittent treatment with human parathyroid hormone (hPTH[1–34]) increased trabecular bone volume but not connectivity in osteopenic rats. J Bone Miner Res 10:14751477.
  • 16
    Lane NE, Haupt D, Modin G, Kinney JH 1998 The acute changes in trabecular bone connectivity and osteoclast activity in a rat model of estrogen deficiency. J Bone Miner Res 13:229236.
  • 17
    Qi H, Li M, Wronski TJ 1995 A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res 10:948952.
  • 18
    Liang H, Pun S, Wronski TJ 1999 Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 140:57805788.
  • 19
    Pun S, Florio CL, Wronski TJ 2000 Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats. Bone 27:197202.
  • 20
    Pun S, Dearden RL, Ratkus AM, Liang H, Wronski TJ 2001 Decreased bone anabolic effects of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone 28:220226.
  • 21
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L 2001 Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. J Bone Miner Res 16:13991407.
  • 22
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ 2002 Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. Endocrinology 143:25152526.
  • 23
    Lane NE, Yao W, Kumer J, Breuning T, Wronski T, Modin G, Kinney JH 2003 Basic fibroblast growth factor partially restores trabecular bone architecture in osteopenic ovariectomized rats. Osteoporos Int. 14:374382.
  • 24
    Laib A, Kumer JL, Majumdar S, Lane N 2001 The temporal changes in trabecular architecture in ovariectomized rats assessed by microCT. Osteoporos Int 12:936941.
  • 25
    Lane NE, Kumer JL, Majumdar S, Khan M, Lotz J, Steven RE, Klein R, Phelps KV 2002 The effects of synthetic conjugated estrogens, A (Cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos Int 13:816823.
  • 26
    Hildebrand T, Rüegsegger P 1997 A new method for the model independent assessment of thickness in three-dimensional images. J Microsc 85:6775.
  • 27
    Lorensen WE, Cline HE 1987 Marching cubes: A high-resolution 3D surface construction algorithm. Comput Graph 21:163169.
  • 28
    Hildebrand T, Rüegsegger P 1997 Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1:1523.
  • 29
    Lane NE, Haupt D, Kimmel DB, Modin G, Kinney JH 1999 Early estrogen treatment replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat. J Bone Miner Res 14:206212.
  • 30
    Lane NE, Haupt D, Modin G, Haupt D, Kimmel DB, Modin G, Kinney JH 1998 The acute change in trabecular bone connectivity and osteoclast activity in a rat model of estrogen deficiency. J Bone Miner Res 13:229236.
  • 31
    Maeda H, Kimmel DB, Raab D, Lane NE 1993 The musculoskeletal response to immobilization and recovery. Bone 14:153159.
  • 32
    Parfitt AM, Drezner MK, Glorieux FH, Janis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Committee. J Bone Miner Res 2:595610.
  • 33
    Parfitt AM, Matthews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, area, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:13961409.
  • 34
    Balooch M, Wu-Magidi IC, Balazs A, Lundkvist AS, Marshall SJ, Marshall GW, Siekhaus WJ, Kinney JH 1998 Viscoelastic properties of demineralized human dentin measured in water with atomic force microscopic based indentation. J Biomed Mater Res 40:539544.
  • 35
    Balooch G, Marshall GW, Marshall SJ, Warren OL, Asif SAS, Balooch M 2003 Calcified tissue interfaces: Evaluation by a new modulus mapping technique. J Biomech (in press)
  • 36
    Dunstan CR, Boyce R, Boyce BF, Garrett IR, Izbicka E, Burgess WH, Mundy GR 1999 Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res 14:953959.
  • 37
    Faulkner KG, McClung M, Cumming SR 1994 Automated evaluation of hip axis length for predicting hip fracture. J Bone Miner Res 9:10651070.
  • 38
    Duan Y, Parfitt M, Seeman E 1999 Vertebral bone mass, size and volumetric density in women with spinal fracture. J Bone Miner Res 14:17961802.
  • 39
    Ito M, Nishida A, Koga A, Ikeda S, Shiraishi A, Uetani M, Hayashi K, Nakamura T 2002 Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters. Bone 31:351358.
  • 40
    Kinney JH, Haupt DL, Balooch M, Ladd AJC, Ryaby JT, Lane NE 2000 Three-dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: Biomechanical implications. J Bone Miner Res 15:19811991.
  • 41
    Bell GH, Dunbar O, Beck JR, Gibb A 1967 Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Int 1:7586.
  • 42
    Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationship between surface, volume, and thickness of iliac trabecular bone in aging and osteoporosis. J Clin Invest 72:277282.
  • 43
    Kleerekoper M, Villanueva AR, Stanciu T, Rao DS, Parfitt AM 1985 The role of three-dimensional trabecular microarchitecture in the pathogenesis of vertebral compression fracture. Calcif Tissue Int 37:594597.
  • 44
    Weinstein RS, Hutson MS 1987 Decreased trabecular width and increased trabecular spacing contributed to bone loss with aging. Bone 8:137142.
  • 45
    Recker RR 1993 Architecture and vertebral fracture. Calcif Tissue Int 53:S139S142.
  • 46
    Kinney JH, Ladd AJC 1998 The relationship between three-dimensional connectivity and the elastic properties of trabecular bone. J Bone Miner Res 13:839845.
  • 47
    Pistoia W, van Rietbergen B, Lochmüller EM, Lill CA, Eckstein F, Rüegsegger P 2002 Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 30:842848.
  • 48
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:14341441.
  • 49
    Kinney JH, Marshall SJ, Marshall GW 2003 The mechanical properties of human dentin: A critical review and reevaluation of the dental literature. Crit Rev Oral Biol Med 14:1329.
  • 50
    Balooch M, Demos SG, Kinney JH, Marshall GW, Balooch G, Marshall SJ 2001 Local mechanical and optical properties of normal and transparent root dentin. J Mater Sci Mater Med 12:507514.
  • 51
    Gospodarowicz D 1991 Biological activities of fibroblast growth factors. In: BairdA, KlagsbrunM (eds.) The Fibroblast Growth Factor Family, Vol. 638. New York Academy of Sciences, New York, NY, USA, pp. 18.
  • 52
    Mazue G, Bertolero F, Garofano L, Brughera M, Carminati P 1992 Experience with preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett 65:329338.
  • 53
    Iwaniec UT, Magee KA, Mitova-Caneva NG, Wronski TJ 2002 Bone anabolic agents of subcutaneous treatment with basic fibroblast growth factor in ovariectomized rats. J Bone Miner Res 17:S1;S376.